Biovision has been organized since 1999 to bring together decision-makers from the academic, political, private and public sectors. Their aim is to incentivize debate on the life sciences and their impact on society, as well as turning innovative ideas into real solutions for the people.
The the theme of Biovision 2017 will be ‘From Global health to One health’ and will feature the 12th edition of Prospective and the 5th edition of Catalyzer and Investor programs.
The fair is articulated through three pillars:
Biovision Prospective aims at debating major issues with experts, key opinion leader and challengers to reach salient conclusions in order to take action for the citizen.
The Catalyzer program allows selected innovative life sciences Projects and seed stage Startups to connect with potential partners and pitch in front of a prestigious selection committee.
The Investor program is dedicated to innovative life sciences startups seeking series A or series B funds within 18 months. The international selection committee gathers more than 15 leading European Venture funds.